{
    "Trade/Device Name(s)": [
        "Human C4 Kit for use on SPApLUS"
    ],
    "Submitter Information": "The Binding Site Group, Ltd.",
    "510(k) Number": "K100455",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "DBI"
    ],
    "Summary Letter Date": "August 25, 2010",
    "Summary Letter Received Date": "August 26, 2010",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.5240"
    ],
    "Regulation Name(s)": [
        "Complement components immunological test system"
    ],
    "Analyte Class(es)": [
        "immunology"
    ],
    "Analyte(s)": [
        "Human C4"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Binding Site SPApLus turbidimetric analyser"
    ],
    "Method(s)/Technology(ies)": [
        "Turbidimetric analysis"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for Human C4 Kit for quantitative in vitro measurement of human C4 in serum using SPApLus analyser.",
    "Indications for Use Summary": "Intended for the quantitative in vitro determination of human C4 in serum using the Binding Site SPApLus turbidimetric analyser, to be used in conjunction with other laboratory and clinical findings.",
    "fda_folder": "Immunology"
}